N-FIS was developed to address a critical challenge in healthcare-needle phobia

Integri Medical has launched a needle-free injection system N-FIS) to address needle phobia and enhance patient convenience. In this interview, Sarvesh Mutha, MD, IntegriMedical discusses the technology behind the device and plans for scaling this innovation worldwide, in an interaction with Viveka Roychowdhury

-  Viveka Roychowdhury

Give a short background of the founders IntegriMedical is led by a team of experienced professionals with a strong background in medical technology, business development and healthcare innovation. The key leadership team includes myself, Ankur Naik, MD, Scott McFarland, CEO and Mark Timm, COO. With over two decades of entrepreneurial experience, I have been at the forefront of medtech innovations, strategic partnerships, and business expansion. As Managing Director of IntegriMedical, I oversee the company's strategic vision, spearheading efforts to drive business growth, expand market reach, and accelerate the adoption of needle-free injection technology.

How did the founders decide to venture into the needlefree injection system (N-FIS) and what is its USP compared to existing systems? How does it fare on the cost front? What does it mean for patients?

N-FIS was developed to address a critical challenge in healthcare-needle phobia. Research has reported that fear of needles constitutes about 20-50 per cent among children and 20-30 per cent among adults globally; often leading to missed vaccinations and delayed treatments. In addition, conventional needles expose patients to risk of cross-contamination and potential needle stick injuries to healthcare professionals. Recognising the need for a safer, more patient-friendly alternative, we set out to find a better solution-and that's how N-FIS was born.